Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.

TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...

TAMPA, Fla./LONDON - Akari Therapeutics, Plc (NASDAQ:AKTX) announced Tuesday the initiation of GMP manufacturing activities for AKTX-101, its lead antibody drug conjugate (ADC) program, partnering ...

TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...

Gilead Sciences GILD recently announced that it has exercised its combined option to exclusively license Assembly Biosciences’ ASMB herpes simplex virus (HSV) helicase-primase inhibitor programs. The ...

Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...

Four hundred and eighty-two members of African Democratic Congress (ADC) and 53 special delegates yesterday elected ex-Speaker of Osun State House of Assembly, Dr. Najeem Salaam, as the governorship ...

HONOLULU (Island News) – In an effort to keep pets safe during the holiday season, the Hawaiian Humane Society (HHS) launched its Microchip Madness initiative to help families protect their ...

Microchip issued a press release indicating its December quarter would come in at the high end of guidance. The company has experienced a massive hangover following the pandemic-era industrial chip ...

A phone call between a veterinarian and a cat’s former owners—triggered by a routine microchip scan—led to a shocking resolution that left Instagram users up in arms Krista Magnifico, veterinarian and ...